Request Demo
Roundup: South Korean AI software for sepsis detection gets US FDA nod and more briefs
23 Jun 2023
Clinical StudyImmunotherapy
Photo courtesy of SpassMed
SpassMed scores US FDA 510(k) for AI sepsis detection software
The AI solution called SpassageQ has been approved as softUnited States Food and Drug Administrationepsis, anaphylaxis, and hypovolemic shosepsis
South Korean researchers use AI to predict immunotherapy side effectssepsisanaphylaxishypovolemic shock
Researchers from various South Korean universities have teamed up to develop an AI model for predicting the side effects of immunotherapy on cancer patients.
Korea Advanced Institute of Science and Technology and Asan Medical Center first came up with a comprehensive list of risk factors of the sidcancercts of immuno-oncology drugs based on patients' genomes, transcriptomes, and blood indicators. This was extracted from a large-scale prospective cohort of solid cancer patients, in partnership with nine South Korean medical institutions.
Korea Advanced Institute of Science and TechnologyvelopAsan Medical Centerwhether a patient will show side effects to immunotherapy prior to getting it.solid cancer
The research was done given the lack of understanding of such side effects, which have been found to be similar to autoimmune diseases, and in the worst case, can even lead to death.
Fujifilm India launches mobile app for providersautoimmune diseases
Fujifilm India has launched a mobile app where healthcare providers can manage the service and support for their medical diagnostic devices.
Fujifilm IndiaOS and Android phones, Fujifilm Connect allows the submission and tracking of service requests, viewing of maintenance records, and monitoring of device performances. It also has features that aid in customer support services, such as a 24/7 call logging process and real-time contract status visibility.
KT Corp. to develop Vietnamese medicaFujifilmlatform with Dong-A ST
KT Corp.unications giant KT Corporation from South Korea is collaborating with Dong-A ST, a pharmaceutical company in Vietnam, to create a medical information platform in the Vietnamese language.
The partnership aims to cKT Corporationabout South Korean medical technology foDong-A STese medical workers. According to a media release, the platform is targeted to be released in July.
TatvaCare to launch clinical trial of COPD DTx
Indian health tech company TatvaCare iCOPDunching a clinical trial of its digital therapeutic solution, MyTatva, for people with chronic respiratory disorders.
The digital-based solution MyTatva combines personalised care plans, IoT device monitoring, coaching, and counselling services tochronic respiratory disorders with their care programme.
According to a press release, the BREATHE DTx trial seeks to test the efficacy and acceptability of the DTx for COPD and asthma. It will also gauge its capability to reduce exacerbations and incidents.
Tags: SpassMed, Korea Advanced Institute of Science and Technology, South Korea, Fujifilm, India, KT Corp, TatvaCare
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.